AAK1 Knockout Cell Line (A549)

The choice depends on whether you are studying AAK1 (AP2-associated kinase 1)'s role in clathrin-mediated endocytosis or modeling its emerging functions as an antiviral and neuropathic pain target. The Knockout line is the standard tool for asking whether AAK1 is required for these processes — AAK1 is a Ser/Thr kinase that phosphorylates the μ2 subunit of the AP2 adaptor complex (T156), enhancing AP2-cargo interaction during clathrin-mediated endocytosis; AAK1 regulates receptor internalization and is hijacked by multiple viruses for entry. Overexpression is useful for studying AAK1 gain-of-function effects. For endocytosis and antiviral research, the EDITGENE AAK1 Knockout in A-549 is uniquely valuable — A-549 is a relevant epithelial/respiratory context for viral entry studies. Rescue with wild-type or kinase-dead AAK1 enables structure-function studies. The knockout is a critical specificity tool for ⭐ AAK1 inhibitors: ⭐ baricitinib (Olumiant, JAK inhibitor with AAK1 activity, repurposed for COVID-19 based in part on predicted AAK1-mediated antiviral effects on viral endocytosis), LP-935509, SGC-AAK1-1, and emerging AAK1-targeted approaches in neuropathic pain (AAK1 knockout mice show reduced pain) and antiviral therapy.

Primary applications: • Clathrin-mediated endocytosis: AP2 μ2 subunit (T156) phosphorylation and receptor internalization analysis in AAK1-null cells. • Antiviral research: in heterologous viral entry contexts, AAK1's role in virus endocytosis. • AAK1 inhibitor specificity: critical genetic control for ⭐ baricitinib (COVID-19 repurposing based on AAK1 antiviral hypothesis), LP-935509, SGC-AAK1-1. • Neuropathic pain: in heterologous pain-relevant contexts, AAK1's pain-signaling role. EDITGENE recommends this A-549-based model for researchers investigating clathrin-mediated endocytosis, antiviral mechanisms, and emerging AAK1-targeted therapeutics.

Yes. AAK1 rescue experiments are well-established for endocytosis research: • Construct design: use a codon-modified AAK1 sequence with a small C-terminal tag (FLAG, HA). AAK1 has N-terminal kinase domain and C-terminal clathrin/AP2-binding region — preserve all elements. • Kinase-dead rescue: K74A mutation in the ATP-binding lysine abolishes catalytic activity. • Functional readout: rescue should restore AP2 μ2 (T156) phosphorylation and clathrin-mediated endocytosis. A-549-specific considerations: • A-549 is a human non-small cell lung carcinoma (NSCLC) cell line widely used for lung cancer drug development. • Lentiviral transduction is supported with moderate efficiency. • A-549 is a versatile epithelial background for kinase and trafficking research.